Literature DB >> 3316992

Epidemiology of hay fever and perennial allergic rhinitis.

E R Weeke1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316992

Source DB:  PubMed          Journal:  Monogr Allergy        ISSN: 0077-0760


× No keyword cloud information.
  17 in total

Review 1.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  Economic outcomes for the treatment of allergic rhinitis.

Authors:  C M Kozma; M K Sadik; M L Watrous
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

Review 3.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

4.  Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countries.

Authors:  C G Pinto; A Lafuma; F Fagnani; M J Nuijten; G Berdeaux
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany.

Authors:  P K Schädlich; J G Brecht
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

6.  Labelling of rhinitis and hayfever by doctors.

Authors:  B Sibbald; E Rink
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

7.  Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.

Authors:  M Kidd; S H McKenzie; I Steven; C Cooper; R Lanz
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

8.  Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history.

Authors:  B Sibbald; E Rink
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

Review 9.  Drug treatment of allergic conjunctivitis. A review of the evidence.

Authors:  G Ciprandi; S Buscaglia; P M Cerqueti; G W Canonica
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

Review 10.  The pharmacokinetic properties of topical levocabastine. A review.

Authors:  J Heykants; A Van Peer; V Van de Velde; E Snoeck; W Meuldermans; R Woestenborghs
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.